Agalimmune, a biopharmaceutical company, has been created to develop innovative immunotherapeutics for the treatment of cancer, with a focus on solid tumours. The new company has been founded by an investment group comprising Loxbridge ...
Tags: solid tumours, cancer treatment
Singapore has officially opened Single-Cell Omics Centre (SCOC) to speed up the understanding of how individual cells work, and how diagnosis and treatment might be improved through insight derived from single cells. The SCOC is a ...
Leading oncology company Incanthera has launched a partnership with global investment group Technomark Life Sciences. The two businesses will work together to prepare ICT2588 - Incanthera’s revolutionary treatment for solid tumours ...
Tags: Life Sciences, clinical trials, medical
Arno Therapeutics has received orphan-drug designation for AR-42 to treat neurofibromatosis type 2 (NF2) in the Europe. AR-42 is a broad-spectrum deacetylation inhibitor of both histone and non-histone proteins. The orally ...
Tags: Orphan-Drug designation, inhibitor, AR-42, clinical product